WallStSmart

GE HealthCare Technologies Inc. (GEHC)vsViemed Healthcare Inc (VMD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 7531% more annual revenue ($20.63B vs $270.28M). GEHC leads profitability with a 10.1% profit margin vs 5.5%. GEHC trades at a lower P/E of 15.6x. GEHC earns a higher WallStSmart Score of 60/100 (C+).

GEHC

Buy

60

out of 100

Grade: C+

Growth: 4.0Profit: 7.0Value: 7.3Quality: 4.3
Piotroski: 2/9Altman Z: 1.34

VMD

Buy

56

out of 100

Grade: C

Growth: 8.7Profit: 5.5Value: 8.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GEHCSignificantly Overvalued (-156.0%)

Margin of Safety

-156.0%

Fair Value

$30.94

Current Price

$72.20

$41.26 premium

UndervaluedFair: $30.94Overvalued
VMDUndervalued (+51.2%)

Margin of Safety

+51.2%

Fair Value

$17.32

Current Price

$9.35

$7.97 discount

UndervaluedFair: $17.32Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEHC2 strengths · Avg: 8.5/10
Return on EquityProfitability
22.4%9/10

Every $100 of equity generates 22 in profit

P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

VMD3 strengths · Avg: 8.0/10
Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
25.5%8/10

Revenue surging 25.5% year-over-year

EPS GrowthGrowth
29.8%8/10

Earnings expanding 29.8% YoY

Areas to Watch

GEHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.704/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-17.7%2/10

Earnings declined 17.7%

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

VMD2 concerns · Avg: 3.0/10
Market CapQuality
$354.37M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
5.5%3/10

5.5% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : GEHC

The strongest argument for GEHC centers on Return on Equity, P/E Ratio.

Bull Case : VMD

The strongest argument for VMD centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 25.5% demonstrates continued momentum.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.

Bear Case : VMD

The primary concerns for VMD are Market Cap, Profit Margin.

Key Dynamics to Monitor

GEHC profiles as a value stock while VMD is a growth play — different risk/reward profiles.

VMD carries more volatility with a beta of 1.23 — expect wider price swings.

VMD is growing revenue faster at 25.5% — sustainability is the question.

GEHC generates stronger free cash flow (917M), providing more financial flexibility.

Bottom Line

GEHC scores higher overall (60/100 vs 56/100). VMD offers better value entry with a 51.2% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Viemed Healthcare Inc

HEALTHCARE · MEDICAL DEVICES · USA

Viemed Healthcare, Inc. provides durable home medical equipment and post-acute respiratory health care services to patients in the United States. The company is headquartered in Lafayette, Louisiana.

Want to dig deeper into these stocks?